1. Home
  2. PFX vs BTMD Comparison

PFX vs BTMD Comparison

Compare PFX & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

N/A

Current Price

$44.56

Market Cap

89.7M

Sector

Finance

ML Signal

N/A

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.10

Market Cap

80.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFX
BTMD
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.7M
80.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PFX
BTMD
Price
$44.56
$2.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.5K
175.3K
Earning Date
02-06-2026
03-11-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
270.48
EPS
2.06
0.78
Revenue
$25,262,322.00
$195,645,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.80
P/E Ratio
$20.61
$2.80
Revenue Growth
13.89
1.34
52 Week Low
$41.00
$2.09
52 Week High
$57.40
$5.93

Technical Indicators

Market Signals
Indicator
PFX
BTMD
Relative Strength Index (RSI) 53.15 29.34
Support Level $42.88 $2.09
Resistance Level $43.75 $2.21
Average True Range (ATR) 0.66 0.12
MACD -0.06 -0.03
Stochastic Oscillator 53.78 0.85

Price Performance

Historical Comparison
PFX
BTMD

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Share on Social Networks: